Cellserve GmbH

The Solution

The Solution

Introducing CardAPcells

Development of a curative, less invasive cell therapy for heart insufficiency:

The first curative treatment for regeneration of the diseased heart tissue and an extension of the lifetime will be possible.

Current therapies can maintain the current state of the damaged heart at best without actual improvement. 

With CardAPCells, the pumping power of a weakened heart muscle can be strengthend, so that heart failure or heart transplantation can be avoided.

Heart Transplantation

Drug Therapy

Our patented cell therapy combines the best of both current approaches!

CardAPCells Therapy

Scroll to Top